Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

Correction: Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight (Frontiers in Oncology, (2025), 15, (1695468), 10.3389/fonc.2025.1695468) (2026) Dinç U, Sarkar J, Schubert P, Semrau S, Weissmann T, Karius A, Brand J, et al. Journal article, Erratum Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy (2026) Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, et al. Journal article Comprehensive geometry-based plan quality score for lung VMAT (2026) Brand J, Szkitsak J, Lobão R, Axer BN, Pieper L, Ott O, Haderlein M, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article Radiotherapy and DNA damage response inhibitors modestly sensitize HNSCC to NK cell killing, with ATM inhibition more effective than ATR inhibition (2026) Steinsdörfer L, Zülch L, Schäfer A, Frey B, Corradini S, Fietkau R, Gaipl U, Jost T Journal article Brachytherapy in vulvar cancer: Clinical outcome and safety from a single center experience (2026) Oleszczuk A, Strnad V, Lotter M, Kreppner S, Strnad A, Frei C, Weissmann T, et al. Journal article Reply to: “Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology, ” “Key Methodological Considerations in the Interpretation of the CONKO-007 Trial, ” and “Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer” (2026) Fietkau R Journal article Efficacy and safety of salvage brachytherapy for local recurrence after radiotherapy for prostate cancer (2026) Merten R, Strnad V, Lotter M, Kreppner S, Frei C, Schweizer C, Fietkau R, et al. Journal article Inhibiting the DNA damage repair of HNSCC cells in combination with normo-fractionated radiotherapy influences clonogenicity, senescence and expression of NK cell activation markers (2025) Jost T, Wachter M, Meidenbauer J, Fietkau R, Gaipl U Journal article A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastoma (2025) Gomaa A, Huang Y, Stephan P, Breininger K, Frey B, Dörfler A, Schnell O, et al. Journal article